Dishman Carbogen Amcis Ltd's subsidiary completes USFDA inspection at its Bubendorf facility

Dishman Carbogen Amcis Limited's wholly owned subsidiary, CARBOGEN AMCIS AG's manufacturing site in Bubendorf, Switzerland, has successfully completed a routine U.S. Food and Drug Administration (FDA) inspection.

The inspection was concluded without any major or critical observations.

Shares of Dishman Carbogen Amcis Limited was last trading in BSE at Rs. 101.40 as compared to the previous close of Rs. 99.15. The total number of shares traded during the day was 347612 in over 4360 trades.

The stock hit an intraday high of Rs. 102.70 and intraday low of 96.45. The net turnover during the day was Rs. 34788438.00.

Source : Equity Bulls

Keywords

DishmanCarbogenAmcis INE385W01011 DCAL CarbogenAmcisAG Bubendorf Switzerland USFDA Inspection